MeSH definition : An ADAMTS protease that contains eight thrombospondin (TS) motifs. It cleaves VON
WILLEBRAND FACTOR to control vWF-mediated THROMBOSIS. Mutations in the ADAMTS13 gene
have been identified in familial cases of PURPURA, THROMBOTIC THROMBOCYTOPENIC and
defects in ADAMTS13 activity are associated with MYOCARDIAL INFARCTION; BRAIN ISCHEMIA;
PRE-ECLAMPSIA; and MALARIA.;
MeSH synonym : von Willebrand Factor-Cleaving Protease; von Willebrand Factor Cleaving Protease; ADAMTS13 Protease; vWF-Cleaving Protease; vWF Cleaving Protease; ADAMTS-13 Protein; ADAMTS 13 Protein; A Disintegrin and Metalloproteinase with Thrombospondin Motifs 13 Protein;
An ADAMTS protease that contains eight thrombospondin (TS) motifs. It cleaves VON
WILLEBRAND FACTOR to control vWF-mediated THROMBOSIS. Mutations in the ADAMTS13 gene
have been identified in familial cases of PURPURA, THROMBOTIC THROMBOCYTOPENIC and
defects in ADAMTS13 activity are associated with MYOCARDIAL INFARCTION; BRAIN ISCHEMIA;
PRE-ECLAMPSIA; and MALARIA.
https://www.has-sante.fr/jcms/p_3586231/fr/adzynma-adamts13r-purpura-thrombotique-thrombocytopenique-congenital-pttc 2025 false false false France ADAMTS13 Protein Apadamtase Alfa enzyme replacement therapy congenital thrombotic thrombocytopenic purpura adult child treatment outcome insurance, health, reimbursement orphan drug production injections, intravenous Congenital thrombotic thrombocytopenic purpura evaluation of the transparency committee purpura, thrombotic thrombocytopenic
--- https://ansm.sante.fr/tableau-marr/adamts13r 2024 false false false France French risk management ADAMTS13 Protein guidelines for drug use drug hypersensitivity drug hypersensitivity signs and symptoms patient education handout enzyme replacement therapy adult child congenital thrombotic thrombocytopenic purpura ADAMTS13 Protein recombinant proteins
--- https://www.ema.europa.eu/en/medicines/human/EPAR/adzynma 2024 false false false Netherlands French English treatment outcome syndication feed summary of product characteristics package leaflet drug evaluation orphan drug production child adult congenital thrombotic thrombocytopenic purpura enzyme replacement therapy ADAMTS13 protein, human recombinant proteins ADAMTS13 Protein ADAMTS13 Protein risk management pregnancy breast feeding drug approval europe injections, intravenous von willebrand factor product surveillance, postmarketing aged apadamtase alfa and cinaxadamtase alfa